Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.27−0.01 (-2.92%)
Close on Nov 12, 2026Market cap $1.69MP/E –Yield –
Co-Diagnostics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Co-Diagnostics's operating income for the twelve months ending Sep 30, 2026 was -$48.22M. For fiscal 2025 it was -$50.17M. The highest annual figure on record is $46.06M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$50.17M | – |
| FY2024 | Dec 31, 2024 | -$40.08M | – |
| FY2023 | Dec 31, 2023 | -$42.71M | – |
| FY2022 | Dec 31, 2022 | -$26.98M | -158.6% |
| FY2021 | Dec 31, 2021 | $46.06M | +10.5% |
| FY2020 | Dec 31, 2020 | $41.69M | – |
| FY2019 | Dec 31, 2019 | -$5.89M | – |
| FY2018 | Dec 31, 2018 | -$6.12M | – |
| FY2017 | Dec 31, 2017 | -$4.56M | – |
| FY2016 | Dec 31, 2016 | -$1.69M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$6.27M | – |
| Q2 FY2026 | Jun 30, 2026 | -$6.20M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.21M | – |
| Q4 FY2025 | Dec 31, 2025 | -$26.54M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.01M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.06M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.55M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.91M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.23M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.68M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.26M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.83M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.94M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.99M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.95M | -201.3% |
| Q4 FY2022 | Dec 31, 2022 | -$26.12M | -353.4% |
| Q3 FY2022 | Sep 30, 2022 | -$6.54M | -147.9% |
| Q2 FY2022 | Jun 30, 2022 | -$4.15M | -135.2% |
| Q1 FY2022 | Mar 31, 2022 | $9.82M | -4.9% |
| Q4 FY2021 | Dec 31, 2021 | $10.31M | -35.7% |
| Q3 FY2021 | Sep 30, 2021 | $13.63M | +13.2% |
| Q2 FY2021 | Jun 30, 2021 | $11.79M | -19.8% |
| Q1 FY2021 | Mar 31, 2021 | $10.33M | – |
| Q4 FY2020 | Dec 31, 2020 | $16.03M | – |
| Q3 FY2020 | Sep 30, 2020 | $12.04M | – |
| Q2 FY2020 | Jun 30, 2020 | $14.71M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.08M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.62M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.65M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.37M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.25M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.82M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.66M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.35M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.28M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.49M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.81M | – |
| Q2 FY2017 | Jun 30, 2017 | -$700.95K | – |
| Q1 FY2017 | Mar 31, 2017 | -$564.37K | – |
| Q4 FY2016 | Dec 31, 2016 | -$444.58K | – |
See a number that looks wrong?